Advertisement

Topics

Latest "Hakushindo Pharmaceutical Co., Ltd." News Stories - Page: 5

17:31 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Hakushindo Pharmaceutical Co., Ltd." found in our extensive news archives from over 250 global news sources.

More Information about Hakushindo Pharmaceutical Co., Ltd. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Hakushindo Pharmaceutical Co., Ltd. for you to read. Along with our medical data and news we also list Hakushindo Pharmaceutical Co., Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hakushindo Pharmaceutical Co., Ltd. Companies for you to search.

Showing "Hakushindo Pharmaceutical" News Articles 101–125 of 8,200+

Thursday 14th March 2019

SCORR Marketing Unveils Sixth Annual Report on Health Science Industry Marketing Trends

SCORR Marketing, a global health science marketing and communications firm, has released its sixth annual survey on marketing trends in the health sciences industry. This report will enable marketing professionals to make evidence-based brand development, strategic planning, and budgeting decisions. “Analyzing how players across the healt...


Moleculin Biotech, Inc.: Moleculin Announces First Patients Treated in European Annamycin Clinical Trial

HOUSTON, TX / ACCESSWIRE / March 14, 2019 / Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates...

GHO Capital acquires stake in Sterling Pharma

European healthcare investor GHO Capital has acquired a majority stake in active pharmaceutical ingredient (API) manufacturer, Sterling Pharma Solutions.


CPhI North America: FPS confirm their presence for 2019

FPS Food and Pharma Systems is a leading company in the pharmaceutical and fine chemical fields, developing, manufacturing and installing worldwide its own range of fine size reduction machines and containment solutions (sterile and highly toxic API)... The post CPhI North America: FPS con

New generic valsartan approved to address shortages

The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers... The post New generic valsartan approved to address shortages appeared first on European Pharmaceutical Review.

Raymond Schinazi Joins Precision BioSciences Board of Directors

Globally recognized leader in antiviral drug discovery and development Precision BioSciences (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS genome editing platform, has appointed Raymond Schinazi, PhD, Hon DSc to its board of directors. Dr. Schinazi is the Frances Winship Walters Professor of ...

Solasia Files New Medical Device Application for episil® in South Korea

Solasia Pharma K.K. (TOKYO:4597, Headquarters:Tokyo, Japan, President & CEO:Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today officially announced that the Company has filed a New Medical Device Application for episil® oral liquid (SP-03, hereinafter “episil®”) to the Regulatory Authority in South Korea....

Brexit impact on cybersecurity to be “considerable and immediate” – deal, or no deal

The UK is set for a historic vote today that will determine whether or not we leave the EU with...Read More... The post Brexit impact on cybersecurity to be “considerable and immediate” – deal, or no deal appeared first on Pharmaceutical Technology.

Future of semiconductor industry: Ten companies predicted to succeed

Intel is the company which is best placed to succeed in the semiconductor sector, according to exclusive theme-based analysis. GlobalData...Read More... The post Future of semiconductor industry: Ten companies predicted to succeed appeared first on Pharmaceutical Technology.

Azelis Buys Canadian Distributor Chemroy

Belgium-headquartered chemicals distributor Azelis has acquired 100% of Canadian distributor Chemroy, strengthening its presence in North America’s northernmost country. With the buy, Azelis said it is gaining a foothold as one of Canada's leading specialty distributors with a strong position in the CASE (coatings, adhesives, construction and ink), food, pharmaceutical, nutraceutical and...

Particle Sciences Appoints VP of Operations

Karen Bossert comes with 30 years of experience in pharmaceutical manufacturing operations, specializing in aseptic processing, lyophilization and more

JSR Establishes US Headquarters for JSR Life Sciences and North American Holding Company

JSR announced today that it will establish a US headquarters for its biotechnology and life sciences focused businesses under the name JSR Life Sciences, LLC effective April 1, 2019. The formation of JSR Life Sciences will centralize leadership and resources to support the company’s value proposition of driving innovation to provide a portfolio of integr...

Esperion unveils positive human trial results for new cholesterol-lowering drug

Esperion said that bempedoic acid is under development as a complementary, cost-effective, once-daily and oral therapy to treat patients with elevated LDL-C. The company has submitted new drug The post Esperion unveils positive human trial results for new cholesterol-lowering drug appeared first on Pharmaceutical Business review.

Parkinson’s disease study reveals how cancer drug reduces toxic protein in brain

The research team used a single low dose of Novartis’ leukemia drug Tasigna (nilotinib) in a phase II clinical trial in Parkinson’s disease patients. The researchers claimed that The post Parkinson’s disease study reveals how cancer drug reduces toxic protein in brain appeared first on Pharmaceutical Business review.

BioArctic announces start of Phase 1 study of ABBV-0805 for Parkinson’s disease

The Phase 1 study in healthy volunteers will investigate the safety and tolerability of ABBV-0805. ABBV-0805 is the most advanced within the portfolio of alpha-synuclein targeting antibodies in-licensed The post BioArctic announces start of Phase 1 study of ABBV-0805 for Parkinson’s disease appeared first on Pharmaceutical Business review.

Chugai's Hemlibra Receives Approval for Severe Hemophilia A Without Factor VIII Inhibitors from the European Commission

Hemlibra is now available for hemophilia A without inhibitors in the EU, following US and Japan Multiple dosing options are available regardless of inhibitor status Chugai Pharmaceutical Co., Ltd....

Chugai’s Hemlibra Receives Approval for Severe Hemophilia A Without Factor VIII Inhibitors from the European Commission

Hemlibra is now available for hemophilia A without inhibitors in the EU, following US and Japan Multiple dosing options are available regardless of inhibitor status Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that Roche received the decision from the European Commi

Pharma industry M&A deals in Q4 2018 total $11.95bn in United States

Total US pharma industry M&A deals in Q4 2018 worth $11.95bn were announced, according to GlobalData’s deals database. Embed this...Read More... The post Pharma industry M&A deals in Q4 2018 total $11.95bn in United States appeared first on Pharmaceutical Technology.

Pharma industry venture financing deals in Q4 2018 total $3.5bn in United States

Total US pharma industry venture financing deals in Q4 2018 worth $3.5bn were announced, according to GlobalData’s deals database. Embed...Read More... The post Pharma industry venture financing deals in Q4 2018 total $3.5bn in United States appeared first on Pharmaceutical Technology.

Which pharmaceutical companies have the most capsule dosed drugs?

This chart shows the pharmaceutical companies with the most capsule dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most capsule dosed drugs… The post Which pharmaceutical companies have the most caps... The post Which pharmaceutical companies have the most capsule dosed drugs? appeared first on Biotechblog.

Wednesday 13th March 2019

Deerfield commits $100m for translational research deal with Harvard

Healthcare investment firm Deerfield Management has formed a strategic partnership with Harvard University for research and development (R&D) focused on...Read More... The post Deerfield commits $100m for translational research deal with Harvard appeared first on Pharmaceutical Technology.

Common antifungal drug offers hope for cystic fibrosis treatment

New research from the University of Illinois and the University of Iowa has showed that a common antifungal drug, called...Read More... The post Common antifungal drug offers hope for cystic fibrosis treatment appeared first on Pharmaceutical Technology.

Gala Pharmaceutical Starts Construction of Its Long Beach California Testing Facility

IRVINE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- IRVINE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (GLPH), a provider of cannabis testing in Southern California, today announced that it has started construction of its state-of-the-art cannabis testing facility in Long Beach, California.  Gala Pharmaceutical's CEO Dr. Rehman is looking forward to meeting the needs...

EXAIR Line Vac air conveyors

EXAIR’s 64 and 76 mm 316 stainless steel Line Vacs are powerful in-line conveyors that transport high volumes of material through an ordinary hose or tube. They are designed for areas such as food and pharmaceutical processing, which require the benefits of 316SS — including chemical and corrosion resistance, performance in high or low temperatures, long service life and low maintenance. The t...

Moleculin Files with FDA for Expedited Approval Pathway for Annamycin

HOUSTON, TX / ACCESSWIRE / March 13, 2019 / Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks